PL374312A1 - Śródbłonkowe komórki macierzyste, populacje, sposoby wyodrębniania oraz ich zastosowanie - Google Patents

Śródbłonkowe komórki macierzyste, populacje, sposoby wyodrębniania oraz ich zastosowanie

Info

Publication number
PL374312A1
PL374312A1 PL02374312A PL37431202A PL374312A1 PL 374312 A1 PL374312 A1 PL 374312A1 PL 02374312 A PL02374312 A PL 02374312A PL 37431202 A PL37431202 A PL 37431202A PL 374312 A1 PL374312 A1 PL 374312A1
Authority
PL
Poland
Prior art keywords
stem cells
methods
populations
isolation
endothelial stem
Prior art date
Application number
PL02374312A
Other languages
English (en)
Other versions
PL210872B1 (pl
Inventor
William C.III Fanslow
Anne-Marie C. Rousseau
Thomas O. Daniel
Original Assignee
Immunex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corporation filed Critical Immunex Corporation
Publication of PL374312A1 publication Critical patent/PL374312A1/pl
Publication of PL210872B1 publication Critical patent/PL210872B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
PL374312A 2001-12-21 2002-12-20 Zastosowanie przeciwciała specyficznego dla P1H12 do wytwarzania wzbogaconej populacji komórek macierzystych oraz wzbogacona populacja komórek macierzystych i populacja komórek potomnych PL210872B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34349801P 2001-12-21 2001-12-21

Publications (2)

Publication Number Publication Date
PL374312A1 true PL374312A1 (pl) 2005-10-03
PL210872B1 PL210872B1 (pl) 2012-03-30

Family

ID=23346359

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374312A PL210872B1 (pl) 2001-12-21 2002-12-20 Zastosowanie przeciwciała specyficznego dla P1H12 do wytwarzania wzbogaconej populacji komórek macierzystych oraz wzbogacona populacja komórek macierzystych i populacja komórek potomnych

Country Status (11)

Country Link
US (1) US7833697B2 (pl)
EP (1) EP1465983B1 (pl)
JP (2) JP2005514062A (pl)
AT (1) ATE462782T1 (pl)
AU (1) AU2002360741B2 (pl)
CA (1) CA2469472C (pl)
DE (1) DE60235836D1 (pl)
ES (1) ES2341948T3 (pl)
MX (1) MXPA04006154A (pl)
PL (1) PL210872B1 (pl)
WO (1) WO2003060077A2 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04006154A (es) 2001-12-21 2004-11-01 Immunex Corp Celulas madre endoteliales, poblaciones y metodos para el aislamiento y uso de las mismas.
US20040258670A1 (en) * 2002-12-05 2004-12-23 Case Western Reserve University Cell-based therapies for ischemia
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
US20070269412A1 (en) * 2003-12-02 2007-11-22 Celavie Biosciences, Llc Pluripotent cells
US20050232905A1 (en) * 2004-03-26 2005-10-20 Yeh Edward T Use of peripheral blood cells for cardiac regeneration
JP2007536936A (ja) * 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
PL1759536T3 (pl) 2004-06-01 2011-10-31 Kwalata Trading Ltd Techniki in vitro z użyciem komórek macierzystych
JP2008528041A (ja) * 2005-01-31 2008-07-31 コグネート セラピューティクス，インコーポレーテッド 内皮細胞の性質を示す脂肪由来成体間質細胞
CA2623405C (en) 2005-09-20 2014-11-25 Immunivest Corporation Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes
US9134237B2 (en) 2005-09-20 2015-09-15 Janssen Diagnotics, LLC High sensitivity multiparameter method for rare event analysis in a biological sample
EP1951864B1 (en) * 2005-11-07 2014-05-07 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
TW200734462A (en) 2006-03-08 2007-09-16 In Motion Invest Ltd Regulating stem cells
WO2008085229A2 (en) * 2006-11-15 2008-07-17 Arteriocyte Inc. Cell-based therapies for treating liver disease
JP5243456B2 (ja) 2007-03-02 2013-07-24 スミス アンド ネフュー ピーエルシー 生物学的サンプルろ過中の超音波、逆流洗浄、およびフィルタ運動によるフィルタ洗浄装置および方法
CN102197129A (zh) 2008-10-24 2011-09-21 可乐丽股份有限公司 细胞培养试剂盒、筛选方法和细胞培养试剂盒的制造方法
RU2497532C2 (ru) * 2008-12-03 2013-11-10 Эморсайт, Инк. Композиции, улучшающие перфузию в области инфаркта и способы восстановления сосудистого повреждения
US20100209399A1 (en) * 2009-02-13 2010-08-19 Celavie Biosciences, Llc Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects
CN103234993A (zh) * 2013-04-11 2013-08-07 哈尔滨体育学院 一种优秀冰雪运动员内皮祖细胞鉴定方法
CN103484423B (zh) * 2013-07-18 2015-06-24 浙江大学 一种分离培养家禽内皮祖细胞的方法
CN113444637B (zh) * 2021-01-28 2022-08-05 潍坊医学院 一种研究内皮祖细胞损伤修护的氢气培养实验系统及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637481A (en) * 1993-02-01 1997-06-10 Bristol-Myers Squibb Company Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
US6852533B1 (en) 1998-01-23 2005-02-08 Cornell Research Foundation, Inc. Purified populations of stem cells
EP1144594A1 (en) * 1998-11-24 2001-10-17 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
MXPA02012067A (es) 2000-06-05 2004-08-19 Univ Columbia Identificacion y uso de celulas endoteliales precursoras derivadas de medula osea par mejorar la funcion del miocardio despues de dano isquemico.
MXPA04006154A (es) 2001-12-21 2004-11-01 Immunex Corp Celulas madre endoteliales, poblaciones y metodos para el aislamiento y uso de las mismas.

Also Published As

Publication number Publication date
CA2469472A1 (en) 2003-07-24
EP1465983A2 (en) 2004-10-13
JP2008148702A (ja) 2008-07-03
EP1465983A4 (en) 2006-01-11
US7833697B2 (en) 2010-11-16
CA2469472C (en) 2013-11-26
JP4447033B2 (ja) 2010-04-07
AU2002360741B2 (en) 2008-07-17
ATE462782T1 (de) 2010-04-15
WO2003060077A2 (en) 2003-07-24
PL210872B1 (pl) 2012-03-30
MXPA04006154A (es) 2004-11-01
JP2005514062A (ja) 2005-05-19
WO2003060077A3 (en) 2003-12-31
EP1465983B1 (en) 2010-03-31
DE60235836D1 (de) 2010-05-12
AU2002360741A1 (en) 2003-07-30
US20030148512A1 (en) 2003-08-07
ES2341948T3 (es) 2010-06-30

Similar Documents

Publication Publication Date Title
EP1465983A4 (en) ENDOTHELIAL STEM CELLS, POPULATIONS, METHODS OF ISOLATION AND USE THEREOF
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
AU2002359522A8 (en) Compositions and methods of selective nucleic acid isolation
WO2002095055A8 (en) Compositions and methods for use in isolation of nucleic acid molecules
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
SG149061A1 (en) Definitive endoderm
AP2000001919A0 (en) Inhibitors of caspases.
GB2393734B (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
WO2006026570A8 (en) Use of stem cells to generate inner ear cells
SG152273A1 (en) Pdx1 expressing endoderm
DE69937888D1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
ATE473751T1 (de) Isolierung und transplantation von retinalen stammzellen
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
EP2266396A3 (en) Modulation of stem cells using zinc finger proteins
MXPA05013553A (es) Pirrolodihidroisoquinolinas como inhibidores de pde10.
WO2003103571A3 (en) Flavivirus vaccines
AU6362100A (en) Derivatized polyurethane compositions and methods of making
PL374080A1 (pl) Sposób wytwarzania fibrynogenu
WO2005047494A3 (en) Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
MXPA03010158A (es) Sulfonamidas.
WO2006031926A3 (en) Methods for the isolation and expansion of cord blood derived t regulatory cells
ITMI20011632A0 (it) Composizione solida contenente spore di batteri non patogeni del genere bacillus
MXPA04003755A (es) Endoprotesis vasculares.
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten